Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching.
Linde L, Ørnbjerg LM, Heegaard Brahe C, Wallman JK, Di Giuseppe D, Závada J, Castrejon I, Díaz-Gonzalez F, Rotar Z, Tomšič M, Glintborg B, Gudbjornsson B, Geirsson AJ, Michelsen B, Kristianslund EK, Santos MJ, Barcelos A, Nordström D, Eklund KK, Ciurea A, Nissen M, Akar S, Hejl Hyldstrup L, Krogh NS, Hetland ML, Østergaard M.
Linde L, et al. Among authors: zavada j.
Rheumatology (Oxford). 2024 Jul 1;63(7):1882-1892. doi: 10.1093/rheumatology/kead494.
Rheumatology (Oxford). 2024.
PMID: 37738257
Free PMC article.